On-target and off-target-based toxicologic effects

Toxicologic Pathology

Volumn 41, Issue 2, 2013, Pages 310-314

  Rudmann, Daniel G ^a  

^a ELI LILLY AND COMPANY   (United States)

Author keywords

mechanism based; off target; on target; pathology; pharmaceuticals; safety assessment; toxicology

Indexed keywords

BIOLOGICAL MARKER; EPLERENONE; GLUCAGON LIKE PEPTIDE 1 RECEPTOR AGONIST; MITOGEN ACTIVATED PROTEIN KINASE 14 INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY Y 1; UNCLASSIFIED DRUG;

ADVERSE OUTCOME; ARTICLE; DRUG CARCINOGENICITY; DRUG TARGETING; GENETIC TRANSCRIPTION; GENOME ANALYSIS; HUMAN; IMMUNOHISTOCHEMISTRY; MEDICAL EDUCATION; MICROARRAY ANALYSIS; NONHUMAN; PATHOLOGIST; PRIORITY JOURNAL; REPRODUCTIVE TOXICITY; RISK ASSESSMENT; TOXICITY; TOXICITY TESTING;

ANIMALS; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; HUMANS; PATHOLOGY; RISK ASSESSMENT; TOXICOLOGY;

EID: 84875714538     PISSN: 01926233     EISSN: 15331601     Source Type: Journal    
DOI: 10.1177/0192623312464311     Document Type: Article

References (15)

1. Eplerenone; MSDS No. sc-203943 (Online); Santa Cruz Biotechnology: Santa Cruz, CA, Dec. 16, 2009, http://datasheets.scbt.com/sc-203943.pdf(accessed October 8, 2012).
2. Foster W. T., Chen S., He A., Truong A., Bhaskaran V., Nelson D. M., Dambach D. M., Lehman-McKeeman L. D., Car B. D.. A retrospective analysis of toxicogenomics in the safety assessment of drug candidates. Toxicol Pathol. 2007 ; 35: 621-35
3. Hartung T.. Toxicology for the twenty-first century. Nature. 2009 ; 460: 208-12
4. Knudsen L. B., Madsen L. W., Andersen S., Almholt K., de Boer A. S., Drucker D. J., Gotfredsen C., Egerod F. D., Hegelund A. C., Jacobsen H., Jacobsen S. D., Moses A. C., Molck A., Nielsen H. S., Nowak J., Solberg H., Thi T., Zdravkovic M.. Glucagon-like peptide-1 receptor agonists activate rodent thyroid C-cells causing calcitonin release and C-cell proliferation. Endocrinology. 2010 ; 151: 1473-86
5. Long G. G.. Commentary on "Evaluation of possible carcinogenic risk to humans based on liver tumors in rodent assays: The two-year bioassay is no longer necessary.". Toxicol Pathol. 2010 ; 38: 502-5
6. Madsen L. W., Knauf J. A., Gotfredsen C., Pilling A., Sjogren I., Andersen S., Anderson L., deBoer A. S., Manova K., Barlaqs A., Vundavalli S., Nyborg N. C., Knudsen L. B., Moelck A. M., Fagin J. A.. GLP-1 receptor agonists and the thyroid: C-cell effects in mice are mediated via the GLP-1 receptor and not associated with RET activation. Endocrinology. 2012 ; 153: 1538-47
7. Morris D. L., O'Neil S. P., Devraj R. J., Portanova J. P., Gilles R. W., Gross C. J., Curtiss S. W., Komocsar W. J., Garner D. S., Happa F. A., Krause L. J., Nikula K. J., Monahan J. B., Selness S. R., Galluppi G. R., Shevlin K. M., Kramer J. A., Walker J. K., Messing D. M., Anderson D. R., Mourey R. J., Whitely L. O., Daniels J. S., Yang J. Z., Rowlands P. C., Alden C. L., Davis J. W., Sagartz J. E.. Acute lymphoid and gastrointestinal toxicity induced by selective p38alpha map kinase and map kinase-activated protein kinase-2 (MK2) inhibitors in the dog. Toxicol Pathol. 2010 ; 38: 606-18
8. Mutlib A. E., Gerson R. J., Meunier P. C., Haley P. J., Chen H., Gan L. S., Davies M. H., Gemzik B., Christ D. D., Krahn D. F., Markwalder J. A., Seitz S. P., Robertson R. T., Miwa G. T.. The species-dependent metabolism of efavirenz produces a nephrotoxic glutathione conjugate in rats. Toxicol Appl Pharmacol. 2000 ; 169: 102-13
9. Nigsch F., Lounkine E., McCarren P., Cornett B., Glick M., Azzaoui K., Urban L., Marc P., Muller A., Hahne F., Heard D. J., Jenkins J. L.. Computational methods for early predictive safety assessment from biological and chemical data. Expert Opin Drug Metab Toxicol. 2011 ; 7: 1497-511
10. Rudmann D. G., Cohen I. R., Robbins M. R., Coutant D. E., Henck J. W.. Androgen dependent mammary gland virilism in rats given the selective estrogen receptor modulator LY206948 hydrochloride. Toxicol Pathol. 2005 ; 33: 711-719
11. Rudmann D. G., Page T. J., Vahle J. L., Chouinard L., Haille S., Poitout F., Baskin G., Lambert A. J., Walker P., Glazier G., Awori M., Bernier L.. Rat-specific decreases in platelet count caused by a humanized monoclonal antibody against sclerostin. Toxicol Sci. 2012 ; 125: 586-94
12. Santostefano M. J., Kirchner J., Vissinga C., Fort M., Lear S.,, Pan W.,, Prince P. J., Hensley K. M., Tran D., Rock D., Vargas H. M., Narayanan P., Jawando R., Rees W., Rendel J. F., Reynhardt K., Everds N.. Off-target platelet activation in macaques unique to a therapeutic monoclonal antibody. Toxicol Pathol. 2012 ; 40: 899-917
13. Thomas R. S., Clewell H. J., Allen B. C., Yang L., Healy E., Andersen M. E.. Integrating pathway-based transcriptomic data into quantitative chemical risk assessment: A five chemical case study. Mut Res. 2012 ; 746: 135-143
14. Waser B., Beetschen K., Pellegata N. S., Reubi J. C.. Incretin receptors in non-neoplastic and neoplastic thyroid C cells in rodents and humans: Relevance for incretin-based diabetes therapy. Neuroendocrinology. 2011 ; 94: 291-301
15. Wetmore B. A., Wambaugh J. F., Ferguson S. S., Sochaski M. A., Rotroff D. M., Freeman K., Clewell H. J., Dix D. J., Andersen M. E., Houck K. A., Allen B., Judson R. S., Singh R., Kavlock R. J., Richard A. M., Thomas R. S. Integration of dosimetry, exposure and high-throughput screening data in chemical toxicity assessment. Toxicol Sci. 2012 ; 125: 157-74